| Electrical stimulation of the anterior nucleus of thalamus for treatment of refractory epilepsy R Fisher, V Salanova, T Witt, R Worth, T Henry, R Gross, K Oommen, ... Epilepsia 51 (5), 899-908, 2010 | 1855 | 2010 |
| De novo mutations in epileptic encephalopathies Nature 501 (7466), 217-221, 2013 | 1474* | 2013 |
| American clinical neurophysiology society’s standardized critical care EEG terminology: 2012 version LJ Hirsch, SM LaRoche, N Gaspard, E Gerard, A Svoronos, ST Herman, ... Journal of clinical neurophysiology 30 (1), 1-27, 2013 | 1091 | 2013 |
| Long-term efficacy and safety of thalamic stimulation for drug-resistant partial epilepsy V Salanova, T Witt, R Worth, TR Henry, RE Gross, JM Nazzaro, D Labar, ... Neurology 84 (10), 1017-1025, 2015 | 709 | 2015 |
| Two‐year seizure reduction in adults with medically intractable partial onset epilepsy treated with responsive neurostimulation: final results of the RNS System Pivotal trial CN Heck, D King‐Stephens, AD Massey, DR Nair, BC Jobst, GL Barkley, ... Epilepsia 55 (3), 432-441, 2014 | 638 | 2014 |
| Long-term treatment with responsive brain stimulation in adults with refractory partial seizures GK Bergey, MJ Morrell, EM Mizrahi, A Goldman, D King-Stephens, D Nair, ... Neurology 84 (8), 810-817, 2015 | 586 | 2015 |
| Randomized trial of three anticonvulsant medications for status epilepticus J Kapur, J Elm, JM Chamberlain, W Barsan, J Cloyd, D Lowenstein, ... New England Journal of Medicine 381 (22), 2103-2113, 2019 | 447 | 2019 |
| Distribution of seizure precipitants among epilepsy syndromes. MM Frucht, M Quigg, C Schwaner, NB Fountain Epilepsia 41 (12), 1534-1539, 2000 | 438 | 2000 |
| Assessment of acute morbidity and mortality in nonconvulsive status epilepticus BF Shneker, NB Fountain Neurology 61 (8), 1066-1073, 2003 | 421 | 2003 |
| Status epilepticus: risk factors and complications NB Fountain epilepsia 41, S23-S30, 2000 | 324 | 2000 |
| De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies S Appenzeller, R Balling, N Barisic, S Baulac, H Caglayan, D Craiu, ... The American Journal of Human Genetics 95 (4), 360-370, 2014 | 317 | 2014 |
| Nine-year prospective efficacy and safety of brain-responsive neurostimulation for focal epilepsy DR Nair, KD Laxer, PB Weber, AM Murro, YD Park, GL Barkley, BJ Smith, ... Neurology 95 (9), e1244-e1256, 2020 | 287 | 2020 |
| Brain‐responsive neurostimulation in patients with medically intractable mesial temporal lobe epilepsy EB Geller, TL Skarpaas, RE Gross, RR Goodman, GL Barkley, CW Bazil, ... Epilepsia 58 (6), 994-1004, 2017 | 265 | 2017 |
| Essential services, personnel, and facilities in specialized epilepsy centers—revised 2010 guidelines DM Labiner, AI Bagic, ST Herman, NB Fountain, TS Walczak, RJ Gumnit, ... Epilepsia 51 (11), 2322-2333, 2010 | 240 | 2010 |
| Pathophysiology of status epilepticus NB Fountain, EW Lothman Journal of clinical neurophysiology 12 (4), 326-342, 1995 | 231 | 1995 |
| Sleep deprivation activates epileptiform discharges independent of the activating effects of sleep NB Fountain, JS Kim, SI Lee Journal of Clinical Neurophysiology 15 (1), 69-75, 1998 | 222 | 1998 |
| Functional anatomy of limbic epilepsy: a proposal for central synchronization of a diffusely hyperexcitable network EH Bertram, P Mangan, N Fountain, D Rempe Epilepsy research 32 (1-2), 194-205, 1998 | 220 | 1998 |
| Brain‐responsive neurostimulation in patients with medically intractable seizures arising from eloquent and other neocortical areas BC Jobst, R Kapur, GL Barkley, CW Bazil, MJ Berg, GK Bergey, JG Boggs, ... Epilepsia 58 (6), 1005-1014, 2017 | 218 | 2017 |
| Pharmacokinetic study of levetiracetam in children JM Pellock, TA Glauser, EM Bebin, NB Fountain, FJ Ritter, RM Coupez, ... Epilepsia 42 (12), 1574-1579, 2001 | 202 | 2001 |
| Efficacy and safety of levetiracetam in children with partial seizures: an open‐label trial TA Glauser, JM Pellock, EM Bebin, NB Fountain, FJ Ritter, CM Jensen, ... Epilepsia 43 (5), 518-524, 2002 | 201 | 2002 |
